Table 5 Robs/pre ratios of brivaracetam PK parameters for liver cirrhosis after oral administration.
From: Investigating clinical pharmacokinetics of brivaracetam by using a pharmacokinetic modeling approach
Dose (mg) | Population | Cmax (µg/ml) | AUC0–∞ (µg h/ml) | CL (ml/min/kg) | Reference | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Obs | Pre | R-value | Obs | Pre | R-value | Obs | Pre | R-value | |||
100 | CP-A | 2.2369 | 1.840 | 1.2 | 44.51 | 43.0 | 1.0 | 2.398 | 2.312 | 1.03 | |
CP-B | 3.062 | 1.916 | 1.5 | 42.50 | 39.12 | 1.1 | 2.207 | 2.510 | 0.9 | ||
CP-C | 2.541 | 1.597 | 1.6 | 46.30 | 36.90 | 1.25 | 2.167 | 2.910 | 0.74 | ||